Literature DB >> 20676361

Synthesis and Evaluation of Haloacetyl, α-Bromoacryloyl and Nitrooxyacetyl Benzo[b]furan and Benzo[b]thiophene Derivatives as Potent Antiproliferative Agents Against Leukemia L1210 and K562 Cells.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Carlota Lopez Cara, Alberto Casolari, Ernest Hamel, Enrica Fabbri, Roberto Gambari.   

Abstract

Identification of novel and selective anticancer agents remains an important and challenging goal in pharmacological research. In search of new compounds with strong antiproliferative activity and simple molecular structure, we have synthesized three different series of compounds in which different substituents were linked to the 3-amino position of the 2-(3', 4', 5'-trimethoxybenzoyl)-benzo[b]furan or benzo[b]thiophene ring system. These substituents, corresponding to acetyl/haloacetyl, α-bromoacryloyl and nitrooxyacetyl moieties had different electrophilic properties. The benzoheterocycle parent structures were selected because of their reported bioactivities. Compounds bearing a methoxy group at the 6-position of the benzo[b]furan skeleton, were identified as potent antiproliferative agents against the human chronic myelogenous K562 and murine L1210 leukemia cell lines. Comparison of positional isomers indicated that moving the methoxy group from the 6- to the 5- or 7-position yielded inactive compounds. The effects of a selected series of compounds on cell cycle progression correlated well with their strong antiproliferative activity and inhibition of tubulin polymerization. The analysis of structure-activity relationships observed in the series of compounds described here may represent a platform for the design of more active molecules.

Entities:  

Year:  2010        PMID: 20676361      PMCID: PMC2911241          DOI: 10.2174/157018010791526296

Source DB:  PubMed          Journal:  Lett Drug Des Discov        ISSN: 1570-1808            Impact factor:   1.150


  26 in total

1.  Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S.

Authors:  R Gambari; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  Microtubule dynamics and tubulin interacting proteins.

Authors:  C E Walczak
Journal:  Curr Opin Cell Biol       Date:  2000-02       Impact factor: 8.382

3.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

Review 4.  Nitric-oxide releasing molecules: a new class of drugs with several major indications.

Authors:  J L Burgaud; J P Riffaud; P Del Soldato
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 5.  Development of distamycin-related DNA binding anticancer drugs.

Authors:  S Marchini; M Broggini; C Sessa; M D'Incalci
Journal:  Expert Opin Investig Drugs       Date:  2001-09       Impact factor: 6.206

Review 6.  Differentiating therapy in acute myeloid leukemia.

Authors:  M S Tallman
Journal:  Leukemia       Date:  1996-06       Impact factor: 11.528

7.  Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients.

Authors:  C Sornsuvit; S Komindr; S Chuncharunee; P Wanikiat; N Archararit; P Santanirand
Journal:  J Int Med Res       Date:  2008 Nov-Dec       Impact factor: 1.671

8.  Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas.

Authors:  J D Jiang; J Roboz; I Weisz; L Deng; L Ma; J F Holland; J G Bekesi
Journal:  Anticancer Drug Des       Date:  1998-10

Review 9.  Apoptosis in acute leukemia.

Authors:  Dezso Schuler; Béla Szende
Journal:  Leuk Res       Date:  2004-07       Impact factor: 3.156

10.  Nitric oxide-mediated apoptosis in murine mastocytoma.

Authors:  I Kitajima; K Kawahara; T Nakajima; Y Soejima; T Matsuyama; I Maruyama
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

View more
  1 in total

1.  Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Filippo Prencipe; Carlota Lopez-Cara; Riccardo Rondanin; Daniele Simoni; Ernest Hamel; Stefania Grimaudo; Rosaria Maria Pipitone; Maria Meli; Manlio Tolomeo
Journal:  Eur J Med Chem       Date:  2015-11-27       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.